NEW YORK, July 16 - Signature BioScience has acquired Cambridge Discovery Chemistry (CDC) from Millennium Pharmaceuticals, Signature BioScience said Monday. Financial details were not disclosed.

Millennium had acquired CDC, based in Richmond, Calif., as part of its acquisition of UK-based Cambridge Discovery Chemistry Limited, the parent company of CDC, in July 2000. Millennium will continue to operate Cambridge Discovery Chemistry Limited as a wholly-owned subsidiary. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.